Early correction of hyperglycaemia in the course of COVID-19 could result in a decrease in the release of inflammatory cytokines and a reduction in the virus’ ACE binding capacity, consequently resulting in better outcomes [11]. The gene discussed is ACE; the disease is COVID-19.